|
Real-time
Euronext Paris
01:30:10 03/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.2535 EUR | -1.36% |
|
-7.48% | -24.78% |
| 01:23pm | Sensorion Gets Go-ahead in France for Trial of Lead Gene Therapy Candidate for Hearing Loss | MT |
| 11/06 | Sensorion continues its decline despite Stifel's positive outlook |  |
| Market Cap | 13Cr 15Cr 12Cr 11Cr 21Cr 1.45TCr 21Cr 147.53Cr 57Cr 740.57Cr 58Cr 56Cr 2.43TCr | P/E 2026 * |
-34.3x | P/E 2027 * | -5.71x |
|---|---|---|---|---|---|
| Enterprise Value | 3L 3L 3L 2L 5L 3.1Cr 5L 31.56L 12.25L 1.58Cr 12.32L 12.05L 5.2Cr | EV / Sales 2026 * |
0.01x | EV / Sales 2027 * | 20.7x |
| Free-Float |
70.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.36% | ||
| 1 week | -7.48% | ||
| Current month | -5.76% | ||
| 1 month | -8.81% | ||
| 3 months | -35.66% | ||
| 6 months | -30.93% | ||
| Current year | -24.78% |
| 1 week | 0.25 |  | 0.28 |
| 1 month | 0.25 | | 0.3 |
| Current year | 0.22 | | 0.81 |
| 1 year | 0.22 | | 0.81 |
| 3 years | 0.15 | | 1.04 |
| 5 years | 0.15 | | 2.29 |
| 10 years | 0.15 | | 7.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 59 | 01/06/2026 |
Laurene Danon
DFI | Director of Finance/CFO | - | 26/06/2024 |
Bernd Schmidt
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 09/03/2015 | |
Julien Miara
BRD | Director/Board Member | 43 | - |
Khalil Barrage
CHM | Chairman | 61 | 30/03/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/02/26 | Redmile Biopharma Investments III LP
| Buy | Company | 1,89,28,571 | 6.2956% | |
| 31/01/26 | Sofinnova Partners SAS
| Buy | Company | 1,07,14,285 | 3.5636% | |
| 18/04/24 | Redmile Biopharma Investments III LP
| Buy | Company | 27,81,914 | 1.0091% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.36% | -7.48% | -19.01% | -66.95% | 15Cr | |
| -0.02% | -1.09% | +2.00% | +17.50% | 5.01TCr | |
| -0.30% | -2.88% | +429.29% | +496.95% | 4.48TCr | |
| +2.13% | +0.89% | +43.59% | +17.61% | 4.34TCr | |
| +0.87% | -3.73% | +8.96% | +73.17% | 4.11TCr | |
| -0.90% | -3.67% | +14.26% | +48.44% | 3.29TCr | |
| +2.71% | +6.82% | - | - | 1.76TCr | |
| +1.68% | -4.20% | +25.28% | +116.83% | 1.66TCr | |
| +0.63% | +0.33% | +16.51% | +28.90% | 1.46TCr | |
| +3.34% | -1.13% | +80.94% | +39.19% | 1.39TCr | |
| Average | +0.88% | -1.35% | +66.87% | +85.74% | 2.75TCr | |
| Weighted average by Cap. | +0.78% | -1.22% | +92.60% | +121.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.19Cr 2.53Cr 2.06Cr 1.88Cr 3.51Cr 239.34Cr 3.53Cr 24Cr 9.46Cr 122.37Cr 9.51Cr 9.31Cr 401.98Cr | 63.95L 74.13L 60.24L 54.89L 1.03Cr 70Cr 1.03Cr 7.13Cr 2.77Cr 36Cr 2.78Cr 2.72Cr 117.61Cr |
| Net income | -2L -3L -2L -2L -4L -2.59Cr -4L -26.39L -10.24L -1.32Cr -10.3L -10.08L -4.35Cr | -3.61Cr -4.19Cr -3.4Cr -3.1Cr -5.79Cr -395.51Cr -5.84Cr -40Cr -16Cr -202.21Cr -16Cr -15Cr -664.26Cr |
| Net Debt | -13Cr -15Cr -12Cr -11Cr -21Cr -1.45TCr -21Cr -147.21Cr -57Cr -738.98Cr -57Cr -56Cr -2.43TCr | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | €0.2535 | -1.36% | 4,85,479 |
| 02/26/02 | €0.2570 | -3.38% | 6,44,753 |
| 01/26/01 | €0.2660 | -1.12% | 4,40,527 |
| 31/26/31 | €0.2690 | -1.10% | 2,26,164 |
| 28/26/28 | €0.2720 | -0.73% | 3,48,939 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALSEN Stock
Select your edition
All financial news and data tailored to specific country editions
